• 2020

    With effect from 01 April 2020 Stephan Schnabel will take over as Chairman of the HELM AG Executive Board.

    With this, the family-owned company will also once again be family-managed.

  • 2018

    With the participation in the Swiss company Phargentis, HELM develops the advanced therapy of chronic obstructive pulmonary disease (COPD).

  • 2018

    HELM establishes Methanol Joint Venture

    HELM Proman Methanol AG is established on 01 July, in which HELM participates as a majority shareholder along with two long-term business partners. The newly established company is structured as a sales and distribution platform and has a head office in Europe, Asia and America respectively. This creates the optimal conditions for access to key international markets and secures the supply of Methanol to North America.

  • 2018

    North America’s largest methanol plant comes onstream

    The Texan production plant Natgasoline LLC, in which HELM has a participation, commences operation in June. With an annual production capacity of 1.75 mt it is one of the largest plants of this type in the world.

  • 2016

    HELM Kimya distributed 245.000 mt of chemical products

  • 2012

    HELM Kimya achieved to be number 29 biggest Exporter of Pharmaceuticals produced in Turkey among total 455 companies

  • 2012

    Dieter Schnabel takes over as Chairman of the Supervisory Board.

  • 2012

    Hans-Christian Sievers becomes Chairman of the Executive Board of HELM AG on 1 January.

  • 2010

    With 151 million Euro, HELM Kimya achieved first time in history a sales turnover in Turkey of more than 100 million Euro

  • 2009

    In Saudi Arabia, production begins with 330,000 metric tons of vinyl acetate monomer and 460,000 metric tons of acetic acid per annum.

    Of these production volumes, HELM markets 300,000 metric tons and 180,000 metric tons, respectively.

  • 2008

    First export of Pharmaceuticals from Turkey into the European Union

  • 2007

    The Oman Methanol Company, in which HELM holds a stake, starts to operate the production plant in Sohar.

    1.05 million metric tons of methanol are produced there each year. HELM is the exclusive marketing partner.

  • 2006

    Sales revenues of the HELM Group exceed the 5 billion Euro mark for the first time, at Euro 5,811,355.

  • 2005

    With Saudi partners HELM founds a joint venture in order to produce acetic acid and vinyl acetate monomer.

  • 2004

    HELM Kimya started the distribution of liquid Chemicals in Turkey

  • 2004

    HELM invests in the Arab world.

    HELM takes a stake in the Oman Methanol Company (OMC) in Sohar.

  • 1996

    HELM started the first Development of a Pharmaceutical Generic together with a partner in Turkey

  • 1993

    Science advances at HELM.

    The first in-house developed pharmaceutical generic medication Calcitonin, used to combat osteoporosis, is rolled out on the market.

  • 1986

    Foundation of HELM Kimya Ltd. Şirketi

  • 1984

    HELM begins with marketing methanol from Trinidad & Tobago.

    Today 4.1 million mt of methanol per annum are produced in five plants at that location.

  • 1984

    Dieter Schnabel becomes Chairman of the Executive Board.

    Hermann Schnabel hands the management of HELM AG over to his son with the words: "Take care Dieter." The development from trading to international marketing begins.

  • 1978

    HELM becomes a family-owned stock corporation.

  • 1967

    Now the focus also lies on Asia: HELM Japan Ltd. is founded in Tokyo. In the following decades, the international expansion was intensively pursued.

  • 1966

    HELM dares to take the leap across the pond: HELM de México, S.A. is established in Mexico City.

  • 1962

    The first foreign subsidiary is established: HELM Skandinavien A/S, Copenhagen.

  • 1950

    Hermann Schnabel takes over the company from Karl O. Helm.

    With primary focus on chemicals he constitutes the company that today operates worldwide.

  • 1900

    Karl O. Helm establishes an import-export company in Hamburg for merchandise of every description.